Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Studies confirm low-dose oral contraceptive treats acne effectively
Washington - The results of Phase III clinical trials demonstrate the safety and efficacy of a low-dose oral contraceptive containing ethinyl estradiol 20 mcg and levonorgestrel 100 mcg (Alesse) for the treatment of moderate acne, reported Diane M. Thiboutot, M.D., at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
